Bio-Optronics

About Bio-Optronics

In 1985, Dan Kerpelman founded Bio-Optronics in Rochester, New York, with a focus on creating software for healthcare organizations. The company developed products to optimize complex processes within hospitals and research settings. Its key offerings included Clinical Conductor, a widely used Clinical Trial Management System (CTMS), and Momentum, a tool for automated medical staff scheduling. These applications were designed to improve operational efficiency, manage finances, and ensure regulatory compliance for clinical trials. The company grew steadily, building a customer base that included hospital systems, clinical research organizations, and the Department of Veterans Affairs. A significant growth phase began in late 2017 when Bio-Optronics received a $30 million investment from Mainsail Partners, a growth equity firm. This partnership aimed to accelerate product development and expand the company's sales and marketing efforts. A major turning point occurred in March 2021 when Advarra, a market leader in regulatory review and clinical research technology, acquired Bio-Optronics. The acquisition integrated Bio-Optronics' CTMS and other software into Advarra's broader suite of services. This move solidified Advarra's position as a leading technology provider for clinical research sites, combining its existing network with Bio-Optronics' customer base to serve tens of thousands of investigators globally.